<DOC>
	<DOCNO>NCT02159287</DOCNO>
	<brief_summary>Patients Atrial fibrillation ( AF ) make unique group ischemic stroke , mostly cause emboli left atrial appendage . Oral anticoagulation ( Warfarin ) recommend prevention recurrent embolic stroke take several day reach therapeutic international normalize ratio ( INR : 2.5 ) bridging therapy short act intravenous anticoagulant recommend therapeutic INR level reach . A common strategy use intravenous unfractionated heparin ( UFH ) standard activate partial thromboplastin time ( aPTT ) reach initiate warfarin . Another strategy use subcutaneous ( SQ ) injection low-molecular-weight heparin ( LMWH ) eg . Enoxaparin . The investigator compare LMWH UFH , focus risk new stroke mortality rate . METHOD : This study randomize control trial perform 80 patient age 18 75 confirm acute ischemic stroke purely due AF hospitalize Shiraz Medical University affiliate teach hospital . Patients randomly assign two group . A brain CT do confirm absence intracranial hemorrhage ass size cerebral ischemia . First group receive 1 mg enoxaparin ( Clexane , Sanofi , Paris ) per kilogram body weight SQ every 12 hour warfarin 5mg orally everyday drug continue target INR level ( 2.5 ) reach clexane discontinue . The second group receive continuous UFH infusion 1000 unit per hour dose adjust maintain therapeutic aPTT ( two time baseline ) level warfarin start ( 5 mg everyday ) . The investigator follow patient group target INR achieve ( 2.5 ) clexane UFH discontinue . Adverse event assess group three month . Data analyze Statistical Package Social Sciences ( SPSS ) version 15 Chi-square statistic . Main outcome study evaluation new stroke , mortality , central nervous system ( CNS ) hemorrhage , major bleeding , drop unwanted side effect first week three month stroke .</brief_summary>
	<brief_title>Study Efficacy , Safety Tolerability Low Molecular Weight Heparin vs. Unfractionated Heparin Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Enoxaparin</mesh_term>
	<criteria>confirm diagnosis acute ischemic stroke purely due AF AF confirm ECG 24 hour holter monitoring patient need initiation anticoagulation prevention recurrent stroke age le 18 75 cooperation CNS hemorrhage major bleed infarction size one third middle cerebral artery territory National Institutes Health Stroke Scale ( NIHSS ) 20 hypersensitivity IV UFH LMWH inform consent cause stroke except AF pregnancy breast feeding uncontrolled hypertension ( BP 220/120 ) renal , hepatic , respiratory cardiac failure myocardial infarction infectious endocarditis coma vasculitis dissection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>bridge therapy</keyword>
</DOC>